HARROW, INC. — Director's Dealing 2012

Apr 28, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2012-02-15

Reporting Person: Finnegan Paul (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option (Right to Buy)	$0.64	2017-01-22	Common Stock (625000)		Direct
Option (Right to Buy)	$0.9	2017-03-31	Common Stock (125000)		Direct

Footnotes

F1: The stock options, granted on January 23, 2012 and effective as of February 28, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Finnegan's options vest over a 3 year period at a strike price of $0.64, with the initial 250,000 options vesting on January 6, 2013, the next 250,000 options vesting on January 6, 2014, and the final 125,000 options vesting on January 6, 2015.

F2: The stock options, granted on April 1, 2012, were granted pursuant to the Issuer's 2007 Stock Incentive and Awards Plan. Mr. Finnegan's options maintain a strike price of $0.90, and vest quarterly over a one year term with the initial 31,250 options vesting on June 30, 2012, the next 31,250 options vesting on September 30, 2012, the next 31,250 options vesting on December 31, 2012 and the final 31,250 options vesting on March 31, 2013.